FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092250 [Registered on: 04/08/2025] Trial Registered Prospectively
Last Modified On: 02/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Study of Emphysematous pyelonephritis at a Tertiary care Centre. 
Scientific Title of Study   Study of risk factors, clinical profile and outcomes of Emphysematous pyelonephritis at a Tertiary care Centre 
Trial Acronym  EPN 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pakalapati Ananya 
Designation  Senior Resident 
Affiliation  Kasturba hospital, manipal 
Address  Department of Nephrology, Kasturba hospital, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  7396888888  
Fax    
Email  docananyapakalapati@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Shankar Prasad N 
Designation  Professor 
Affiliation  Kasturba hospital, manipal 
Address  Department of Nephrology, Kasturba hospital, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  9739905443  
Fax    
Email  shankarmmcmed@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Mohan V Bhojaraja 
Designation  Associate Professor 
Affiliation  Kasturba hospital, manipal 
Address  Department of Nephrology, Kasturba hospital, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  9902548725  
Fax    
Email  mohan.vb@manipal.edu  
 
Source of Monetary or Material Support  
Department of Nephrology, Kasturba Hospital, Manipal, Udupi, Karnataka India - 576104 
 
Primary Sponsor  
Name  Kasturba Hospital Manipal  
Address  Department of Nephrology, Kasturba Hospital, Manipal, Udupi, Karnataka India - 576104  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pakalapati Ananya  Kasturba Hospital, Manipal  Department of Urology, Kasturba Hospital, Manipal, Udupi
Udupi
KARNATAKA 
7396888888

docananyapakalapati@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KASTURBA MEDICAL COLLEGE AND KASTURBA HOSPITAL INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N10||Acute pyelonephritis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All patients admitted to the Department of Nephrology Urology and Medicine for management of EPN aged over 18 years 
 
ExclusionCriteria 
Details  Patients with incomplete data or Patients who died of a suspected diagnosis of EPN before the diagnosis was confirmed or Patients who had an early transfer to another center after discontinuing treatment at the study center 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Renal outcomes: AKI, AKI requiring RRT, CKD (3 months follow up)
Duration of hospital stay
Requirement of surgical intervention for urinary diversion in the form of DJ stenting/ PCN insertion.
Mortality
 
At the time of admission and discharge.
At 1 month and 3 month follow-up 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="126"
Sample Size from India="126" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="1" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The study will be conducted ambispectively in KMCH, Manipal, MAHE, and the Department of Urology, Nephrology, and General Medicine.
Patients admitted with the diagnosis of emphysematous pyelonephritis in the departments mentioned above during the study period will be included in the study as this is ambispective study consent for the patients who are enrolled prospectively will be taken, for the retrospective patient’s consent will be either taken when the patients come for follow-up.
The patient data will be collected, including demographic details, medical history, examination, radiological imaging, Ultrasonography, CT scan, or MRI scan, along with blood investigations, which include both microbiology and pathological (CBC, RFT, Blood culture) and urine analysis with microscopy and urine culture—a requirement of surgical intervention for urinary diversion in the form of DJ stenting/ PCN insertion. Treatment is given, and the progress of the patient and follow-up will be recorded for both retrospective and prospective patients. The patient’s EPN characteristics will be analyzed in terms of patient demographics, clinical presentation, diagnostic investigations, microbiological findings, treatment modality, prognostic factors, and outcome.
10. Outcome measures:
• Renal outcomes: AKI, AKI requiring RRT, CKD (3 months follow up)
• Duration of hospital stay
• Requirement of surgical intervention for urinary diversion in the form of DJ stenting/ PCN insertion.
• Mortality
• The patient data will be collected, including demographic details, medical history, examination, radiological imaging, Ultrasonography, CT scan, or MRI scan, along with blood investigations, which include both microbiology and pathological (CBC, RFT, Blood culture) and urine analysis with microscopy and urine culture. Treatment is given, and the progress of the patient and follow-up will be recorded for both retrospective and prospective patients. The patient’s EPN characteristics will be analyzed in terms of patient demographics, clinical presentation, diagnostic investigations, microbiological findings, treatment modality, prognostic factors, and outcome.
 
Close